CAR-T Cell Therapy Companies Surge Worldwide
Cade Hildreth - BioInformant
BioInformant.com, World's Largest Publisher of Stem Cell Industry News | Real Estate & Bitcoin Investor | Patriot Holdings, Advisor | Former USA Rugby Player 🏉
The world’s only searchable, sortable database of CAR-T cell therapy companies worldwide that is publicly available.
CAR-T cell therapy is a remarkably promising treatment for cancer patients. It is a type of immunotherapy where doctors collect immune cells, modify them in a laboratory, and provide them the capacity to recognize and kill cancer cells. When infused into a patient, the cells get multiplied and stay in the body as “living drugs.”
Since the first historic CAR-T approvals in 2017, Kymriah (tisagenlecleucel), Yescarta (axicabtagene ciloleucel), Tecartus (brexucabtagene autoleucel), Breyanzi (lisocabtagene maraleucel), Abecma (idecabtagene vicleucel), and Relma-cel (relmacabtagene autoleucel) have reached commercialization.
These historic approvals have driven the CAR-T market to staggering new heights and fueled a frenzy of interest into CAR-T cell therapy development. To track the competitors who compose this rapidly expanding market, BioInformant has released a global database of all known CAR-T cell therapy companies—currently 158 worldwide.
We originally developed this database for our own purposes, but more and more of our readers have requested access to it.
The "Global Database of CAR-T Cell Therapy Companies, 2022" features the following for all known market competitors:
It takes our team of analysts hours of research to uncover these CAR-T cell therapy companies from across the globe and requires the translation of sites and clinical trial programs across dozens of languages.
Thankfully, we have a talented, multilingual team who is up to the task of organizing all known CAR-T companies worldwide. Because we continuously update this database to reflect new competitors entering the CAR-T cell therapy marketplace, we are confident that you will find it to be invaluable resource.
Recommended by LinkedIn
Would you benefit from knowing the identities of all known CAR-T market competitors (158 total)?
If so, through Friday, December 24th only, you can claim this searchable, sortable database for an unusual 50% off:
Happy Holidays,
The BioInformant Team
p.s. Remember to act fast, because this offer expires at midnight on December 24th.
Director, Scientific Affairs | Cell & Gene Therapy
3yWow, amazing resource. Thanks for sharing!
Senior Investment Manager
3yAlita Singer Leon SCOTT
Business Leader-Life Science| Commercial Operations | Growth Enabler| Successful business launches-Oncology, Vaccines, Women’s Health, Bone Health and Cellular Therapeutics.
3yUnfortunately in India, we are going at a snails pace. Not many trails as evidence within Indian population & awareness just started building in major cities. ICMR & CDSCO the two key nodal bodies for NDA need to give fast track approvals for some of the companies interested & who are willing to commercialise.
PhD (CAR T cell Therapy) DST Women Scientist
3yVery informative regarding the world wide companies involved in CART therapy.
Immuno-Oncology, CAR-T cell Therapy, Process Development & cGMP manufacturing
3ySuch a promising technology of CAR T cells has shown big hopes to cancer patients and also bringing the dream of Immunologists to reality